BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250408
DTEND;VALUE=DATE:20250411
DTSTAMP:20260515T102608
CREATED:20250214T121248Z
LAST-MODIFIED:20250214T121248Z
UID:40497-1744070400-1744329599@www.pharmajournalist.com
SUMMARY:15th World Clinical Biomarkers & Companion Diagnostics Summit Europe
DESCRIPTION:As recent advances in small molecules\, ADCs\, cell\, and gene therapies poise novel precision therapies from the bench to the clinic\, the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. \nOver three days\, 170+ key stakeholders from across Europe working in Biomarkers\, Translational Medicine\, Precision Medicine\, and Companion Diagnostics will come together to: \n\nBolster biomarker discovery and validation\nImplement novel technologies and trials\nPioneer digital and AI-enabled innovations\nOptimise drug-diagnostic co-development\nStreamline CDx development and commercialisation\nNavigate IVDR-adherence\n\nWhen? 8th-10th April\, 2025 \nWhere? London\, UK \nSee the brochure: https://ter.li/exx85v \nWith free* tickets available for biopharma\, check our T&Cs\, or view our early bird savings and group discounts: https://ter.li/5uhfl8
URL:http://www.pharmajournalist.com/event/15th-world-clinical-biomarkers-companion-diagnostics-summit-europe/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250409
DTEND;VALUE=DATE:20250411
DTSTAMP:20260515T102608
CREATED:20250228T122457Z
LAST-MODIFIED:20250228T122457Z
UID:40603-1744156800-1744329599@www.pharmajournalist.com
SUMMARY:Tumour Models Summit Nordics
DESCRIPTION:Welcome to the first ever Tumour Models Summit Nordics. This April\, the critically acclaimed Tumour Models series will be coming to the Nordics for the first time ever\, uniting more than seventy pharma\, biotech\, and research leaders across the Nordic biotech landscape. \nThe inherent heterogeneity of cancer – both inter-patient and intra-tumoral – remains a significant challenge in cancer modelling. With only 5% of cancer drugs successfully advancing to clinical trials\, there is a critical need for more accurate and predictive models to guide therapeutic development. \nTo serve this need\, the Tumour Models Summit Nordics will unite pharma\, biotech\, and research leaders from across the thriving Nordic biotech ecosystem to tackle this challenge head-on for the first time ever. Experts working across preclinical\, translational\, discovery\, toxicity\, and biology will gather in Stockholm this April to collaborate and overcome the industry’s biggest obstacles for 2025. As the region’s only industry-led event of its kind\, this summit provides a rare opportunity to connect with top experts from these developmental areas. \nGain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling\, discover strategies to de-risk your studies\, and learn how to refine your drug development pipeline. \nKey highlights of the agenda include: \n\nLeveraging cutting-edge 3D in vitro models with Roche\nTarget/receptor axis modelling with Anocca\nHumanised mouse models with BioInvent\nAdvanced omics data with Curacell\nTreating solid tumours with Hemispherian\n\nPrevious attendees of the Tumour Models Summits in Boston\, San Francisco\, and London have celebrated the summit’s range\, relevance\, and focus with comments such as\, “This summit included the most cutting-edge achievements and potential collaborations in the scientific and industrial world” (Roche)\, and “The conference exceeded my expectations. The talks were very relevant to my day-to-day work as in vivo scientist in a cell therapy company. I enjoyed the networking; attendees were very approachable” (Arsenal Biosciences). \nFind out why they said this and secure your free pass to join us to engage with decision-makers\, explore groundbreaking solutions\, and accelerate the path from lab to patient in today’s rapidly evolving landscape. \nWe’ll see you there! \nGet your free pass now whilst still available: https://ter.li/qdc9zo
URL:http://www.pharmajournalist.com/event/tumour-models-summit-nordics/
LOCATION:Hilton Stockholm Slussen\, Guldgränd 8\, Stockholm\, 104 65\, Sweden
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR